Source: Eur Respir J 2016; 47:1299-1303
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Pavord Ian D., Agusti Alvar. Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease. Eur Respir J 2016; 47:1299-1303

Member's Comments

No comment yet.

Related content which might interest you: Blood eosinophil as a treatable trait in patients with bronchiectasis Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Peripheral eosinophil count as a biomarker for the management of COPD: not there yet Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017 Year: 2017 Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Blood eosinophil as a biomarker in COPD Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients. Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 ERJ October Podcast: blood eosinophil count as a biomarker in patients with airway disease Source: Eur Respir J 2016; 48: E70 Year: 2016 FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Interpreting blood eosinophil counts in health and obstructive lung disease Source: Eur Respir J, 59 (1) 2102180; 10.1183/13993003.02180-2021 Year: 2022 Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Role of blood neutrophilia as a biomarker in asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018